Skip to main content
Figure 3 | Journal of Immune Based Therapies and Vaccines

Figure 3

From: A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy

Figure 3

HIV-1-specific IL-4 production and lymphocyte proliferative responses. Significant increases in CT.h4S delta cpm in response to HIV-1-specific IL-4 production were seen over the week 17–65 period (A) for groups B (ART + IL-2), C (ART + IL-2 + Remune™) and D (ART + Remune™), but not for group A (ART alone) (data not shown). Patient 11 is shown as an example of an inverse relationship between lymphocyte proliferative stimulation index (SI) (B) and IL-4 production as delta cpm (C) which was evident for 17 of 28 patients who were assessed for IL-4 production.

Back to article page